After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...

Nvidia and Eli Lilly and Co. are partnering to create an artificial intelligence lab in the San Francisco Bay Area to ...

The life sciences world is once again converging in San Francisco as the J.P. Morgan Healthcare Conference kicks off for 2026 ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved ...

Hippocratic AI is building out its life sciences division to accelerate generative and agentic artificial intelligence in the ...

The VCs surveyed invest in various companies, including early-stage startups and large, publicly traded firms. Respondents pointed to Most Favored Nation-style drug price setting policies, the ...

NVIDIA and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to ...

Broadcast Retirement Network's Jeffrey Snyder discusses the state of investment in the life sciences with scientist and ...

New Jersey is emerging as a national leader in AI-driven life sciences, transforming health care, drug discovery and ...

Artificial intelligence developer Anthropic PBC debuted new healthcare and life sciences capabilities in its flagship chatbot ...

The year 2026 will likely see an increase in the number as well as dollar value of merger and acquisition (M&A) deals, according to a report released to coincide with the 43rd Annual J.P. Morgan ...

Anthropic's rollout of a healthcare product for Claude comes one week after OpenAI announced some similar features for ...